This company has been marked as potentially delisted and may not be actively trading. Graf Acquisition Corp IV (GFOR) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock GFOR vs. KLTO, CERO, WINT, APTO, TTNP, ONVO, PALI, GENE, SCNI, and EVAXShould you be buying Graf Acquisition Corp IV stock or one of its competitors? The main competitors of Graf Acquisition Corp IV include Klotho Neurosciences (KLTO), CERo Therapeutics (CERO), Windtree Therapeutics (WINT), Aptose Biosciences (APTO), Titan Pharmaceuticals (TTNP), Organovo (ONVO), Palisade Bio (PALI), Genetic Technologies (GENE), Scinai Immunotherapeutics (SCNI), and Evaxion Biotech A/S (EVAX). These companies are all part of the "biological products, except diagnostic" industry. Graf Acquisition Corp IV vs. Klotho Neurosciences CERo Therapeutics Windtree Therapeutics Aptose Biosciences Titan Pharmaceuticals Organovo Palisade Bio Genetic Technologies Scinai Immunotherapeutics Evaxion Biotech A/S Graf Acquisition Corp IV (NYSE:GFOR) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and community ranking. Which has stronger earnings and valuation, GFOR or KLTO? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGraf Acquisition Corp IVN/AN/A$4.55MN/AN/AKlotho NeurosciencesN/AN/A$1.35MN/AN/A Does the MarketBeat Community prefer GFOR or KLTO? Graf Acquisition Corp IV and Klotho Neurosciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformGraf Acquisition Corp IVN/AN/AKlotho NeurosciencesN/AN/A Which has more risk and volatility, GFOR or KLTO? Graf Acquisition Corp IV has a beta of 0.17, indicating that its stock price is 83% less volatile than the S&P 500. Comparatively, Klotho Neurosciences has a beta of -1.1, indicating that its stock price is 210% less volatile than the S&P 500. Do insiders & institutionals hold more shares of GFOR or KLTO? 28.5% of Graf Acquisition Corp IV shares are held by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are held by institutional investors. 20.0% of Graf Acquisition Corp IV shares are held by company insiders. Comparatively, 2.0% of Klotho Neurosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer GFOR or KLTO? In the previous week, Klotho Neurosciences had 2 more articles in the media than Graf Acquisition Corp IV. MarketBeat recorded 2 mentions for Klotho Neurosciences and 0 mentions for Graf Acquisition Corp IV. Klotho Neurosciences' average media sentiment score of 1.02 beat Graf Acquisition Corp IV's score of 0.00 indicating that Klotho Neurosciences is being referred to more favorably in the news media. Company Overall Sentiment Graf Acquisition Corp IV Neutral Klotho Neurosciences Positive Is GFOR or KLTO more profitable? Klotho Neurosciences' return on equity of 0.00% beat Graf Acquisition Corp IV's return on equity.Company Net Margins Return on Equity Return on Assets Graf Acquisition Corp IVN/A -2.50% 0.09% Klotho Neurosciences N/A N/A -25.89% SummaryGraf Acquisition Corp IV beats Klotho Neurosciences on 5 of the 8 factors compared between the two stocks. Get Graf Acquisition Corp IV News Delivered to You Automatically Sign up to receive the latest news and ratings for GFOR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GFOR vs. The Competition Export to ExcelMetricGraf Acquisition Corp IVBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$1.77M$2.89B$5.45B$19.47BDividend YieldN/A1.90%5.44%3.94%P/E RatioN/A31.0825.6934.56Price / SalesN/A452.98410.1034.72Price / Cash39.15168.6838.3117.51Price / Book-0.903.076.744.70Net Income$4.55M-$72.35M$3.23B$1.02B Graf Acquisition Corp IV Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GFORGraf Acquisition Corp IVN/A$0.17+2.4%N/A-86.4%$1.77MN/A0.002,021Gap DownKLTOKlotho NeurosciencesN/A$0.17-2.7%N/AN/A$4.76MN/A0.00N/AGap UpCEROCERo Therapeutics3.8012 of 5 stars$0.79-7.2%$11.00+1,292.4%-99.5%$4.25MN/A0.008WINTWindtree Therapeutics2.0822 of 5 stars$1.02+2.5%$350.00+34,213.7%-99.6%$3.73MN/A-0.0630APTOAptose Biosciences1.2811 of 5 starsN/A$93.00+∞N/A$3.66MN/A-0.5831Gap DownHigh Trading VolumeTTNPTitan Pharmaceuticals1.4689 of 5 stars$3.84+2.4%N/A-25.5%$3.51M$180,000.00-0.7410Upcoming EarningsAnalyst ForecastNews CoverageGap DownONVOOrganovo0.1898 of 5 starsN/AN/AN/A$3.47M$122,000.00-2.4020Analyst ForecastNews CoverageGap UpPALIPalisade Bio2.9939 of 5 stars$0.79-0.7%$23.00+2,822.5%-89.2%$3.46M$250,000.00-0.0610GENEGenetic TechnologiesN/A$0.77flatN/AN/A$3.37M$7.66M0.0050High Trading VolumeSCNIScinai Immunotherapeutics1.1666 of 5 stars$2.78+0.0%N/A-45.1%$2.60M$452,000.00-0.0120Earnings ReportGap UpEVAXEvaxion Biotech A/S2.6485 of 5 stars$1.45-8.0%$10.00+592.0%-92.0%$2.03M$3.34M-1.0060 Related Companies and Tools Related Companies KLTO Alternatives CERO Alternatives WINT Alternatives APTO Alternatives TTNP Alternatives ONVO Alternatives PALI Alternatives GENE Alternatives SCNI Alternatives EVAX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GFOR) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredVIDEO: Strange New Elon Device to Shock the WorldElon Musk’s Next BIG Bet And this time he plans to dominate a market worth $3.2 trillion. That’s why I’m...Banyan Hill Publishing | SponsoredDrop these 5 stocks now!You think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graf Acquisition Corp IV Please log in to your account or sign up in order to add this asset to your watchlist. Share Graf Acquisition Corp IV With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GFOR Stock Free GFOR Stock Alerts